Broad-Spectrum Effects of Carbohydrate Reduction on Inflammatory and Immune Mediators in Type 2 Diabetes
Open Access
- 17 April 2026
- journal article
- Published by Taylor & Francis in Endocrine Research
- p. 1-17
Abstract
Chronic low-grade inflammation contributes to the development and complications of type 2 diabetes (T2D). Nutritional ketosis improves glycemic control and weight, but its broader immunomodulatory effects are less well defined. In this post-hoc analysis, adults with T2D (n = 195) or prediabetes (n = 89) in a two-year continuous care intervention (CCI) with individualized carbohydrate reduction emphasizing nutritional ketosis were compared with T2D participants receiving usual care (UC, n = 63). Serum was collected at baseline, 1, and 2 years for high-sensitivity CRP, 15 cytokines/adhesion molecules, and comprehensive blood count (CBC)-derived indices. Linear mixed-effects models evaluated longitudinal changes, while regression (including least absolute shrinkage and selection operator, LASSO) examined associations with mean β-hydroxybutyrate (BHB), weight change, HbA1c, and HOMA-IR. Nineteen of 21 markers declined at 1 year in CCI, largely sustained at 2 years; UC showed no changes. Higher BHB predicted reductions in WBC, ICAM-1, VEGF-A, and systemic immune-inflammation index (SII), while weight loss correlated with IL-6, IL-18, IL-1β, and TNF-α. CCI induced broad, durable anti-inflammatory effects, supporting its role in lowering systemic inflammation and cardiometabolic risk.Keywords
This publication has 69 references indexed in Scilit:
- Anti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulinCellular and Molecular Life Sciences, 2022
- Changes in Circulating Cytokines and Adipokines After RYGB in Patients with and without Type 2 DiabetesObesity, 2021
- Effect of Bariatric Surgery on Serum Inflammatory Factors of Obese Patients: a Systematic Review and Meta-AnalysisObesity Surgery, 2019
- The “Big Bang” in obese fat: Events initiating obesity‐induced adipose tissue inflammationEuropean Journal of Immunology, 2015
- Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitusDiabetologia, 2013
- Inflammatory markers and bariatric surgery: a meta-analysisInflammation Research, 2012
- Only C-Reactive Protein, but not TNF-α or IL6, Reflects the Improvement in Inflammation after Bariatric SurgeryObesity Surgery, 2011
- Proinflammatory Cytokines in Obesity: Impact of Type 2 Diabetes Mellitus and Gastric BypassObesity Surgery, 2007
- Risk of Cardiovascular Events Associated With Selective COX-2 InhibitorsJAMA, 2001
- C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes MellitusJAMA, 2001